Everest Organics has announced that it has successfully developed remdesivir API has been in its R&D facility.
Dr Sirisha Srikakarlapudi, Director, EOL – New Product Development said, “lt’s a moment of utmost satisfaction that with hard work of the past few months by Everest Organics R&D team, we have been able to successfully develop remdesivir API at lab scale in a short span of time. In fact, we are poised for the development of more products in the anti-viral segments in the future.”